NASTORAZEPIDE
|
|
|
- CAS号:
- 209219-38-5
- 英文名:
- Z-360
- 英文别名:
- CS-2910;Nastorazepide;Nastorazepide (Z-360);Nastorazepide Calcium;Z360; Z-360; Z 360; NASTORAZEPIDE.;Z360,CCK Receptor,Cholecystokinin Receptor,Inhibitor,Z 360,Nastorazepide,inhibit;3-[[[[(3R)-5-Cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2,3,4,5-tetrahydro-2-oxo-1H-1,5-benzodiazepin-3-yl]amino]carbonyl]amino]benzoic acid;Benzoic acid, 3-[[[[(3R)-5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2,3,4,5-tetrahydro-2-oxo-1H-1,5-benzodiazepin-3-yl]amino]carbonyl]amino]-
- 中文名:
- NASTORAZEPIDE
- 中文别名:
- 化合物NASTORAZEPIDE;(R)-(-)-3-[N′-(1-叔丁基羰基甲基-2-氧代-5-环己基-1,3,4,5-四氢-2H-1,5-苯并二氮杂卓-3-基)脲基]苯甲酸
- CBNumber:
- CB42731173
- 分子式:
- C29H36N4O5
- 分子量:
- 520.62
- MOL File:
- 209219-38-5.mol
|
|
|
NASTORAZEPIDE化学性质
-
沸点:
-
742.8±60.0 °C(Predicted)
-
|
-
密度:
-
1.29±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO:32.0(Max Conc. mg/mL);61.5(Max Conc. mM)
-
|
-
酸度系数(pKa):
-
4.16±0.10(Predicted)
-
|
NASTORAZEPIDE性质、用途与生产工艺
Nastorazepide（Z-360）是一种选择性的, 口服有效的, 1,5-苯并二氮杂环衍生物胃泌素/胆囊收缩素2（CCK-2）受体拮抗剂，具有潜在的抗肿瘤活性。
NASTORAZEPIDE
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/25 | HY-17617 | Nastorazepide | | 1 mg | 502元 |
| 2024/01/25 | HY-17617 | NASTORAZEPIDE
Nastorazepide | 209219-38-5 | 5mg | 1900元 |
209219-38-5, NASTORAZEPIDE 相关搜索:
- C29H36N4O5
- (R)-(-)-3-[N′-(1-叔丁基羰基甲基-2-氧代-5-环己基-1,3,4,5-四氢-2H-1,5-苯并二氮杂卓-3-基)脲基]苯甲酸
- 化合物NASTORAZEPIDE
- 209219-38-5
- Z360,CCK Receptor,Cholecystokinin Receptor,Inhibitor,Z 360,Nastorazepide,inhibit
- CS-2910
- Z360; Z-360; Z 360; NASTORAZEPIDE.
- Benzoic acid, 3-[[[[(3R)-5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2,3,4,5-tetrahydro-2-oxo-1H-1,5-benzodiazepin-3-yl]amino]carbonyl]amino]-
- Nastorazepide Calcium
- 3-[[[[(3R)-5-Cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2,3,4,5-tetrahydro-2-oxo-1H-1,5-benzodiazepin-3-yl]amino]carbonyl]amino]benzoic acid
- Nastorazepide (Z-360)
- Nastorazepide